Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies

Localized brain proton MR spectra were acquired from patients with different mitochondrial encephalomyopathies (myoclonus epilepsy with ragged-red fibers [MERRF], Kearns-Sayre syndrome [KSS], and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS]). The regional brain metabolic abnormalities in patients with these syndromes showed different features consistent with the distinct phenotypes. In MERRF, only one of four patients showed an increase in the lactate/creatine resonance intensity ratio (an index of impairment of oxidative metabolism) in spectra from central (supraventricular) or occipital brain volumes, and this was small. There were significant decreases in N-acetylaspartate/creatine (a measure of neuronal loss or dysfunction) in central cerebral volumes of demented patients and, more prominently, in occipital volumes. In the one patient in whom it was studied, the cerebellum also showed a decreased N-acetylaspartate/creatine. Spectra from two patients with KSS both showed large (four- to sevenfold) increases in lactate/creatine and large decreases in N-acetylaspartate/creatine in central brain volumes. Yet another pattern of regional metabolic abnormality was present in the MELAS syndrome, where proton spectroscopic imaging demonstrated focal localization of abnormally increased lactate/creatine and decreased N-acetylaspartate/creatine to the regions of the stroke-like lesions on conventional MR images. Serial studies emphasized that the regional metabolic abnormalities in MELAS are highly variable as the stroke-like lesions appear and evolve.

[1]  E. Shoubridge,et al.  Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). , 1992, American journal of human genetics.

[2]  G B Matson,et al.  Human brain infarction: proton MR spectroscopy. , 1992, Radiology.

[3]  D. Wallace.  Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.

[4]  J. Valk,et al.  1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders , 1992, Annals of neurology.

[5]  E. Schon,et al.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. , 1992, Molecular and cellular biology.

[6]  A. Harding,et al.  A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. , 1992, Brain : a journal of neurology.

[7]  J. Hayashi,et al.  Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Shoubridge,et al.  In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF) , 1991, Annals of neurology.

[9]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[10]  N. Bresolin,et al.  In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. , 1991, Molecular and cellular biology.

[11]  P. Matthews,et al.  Correlative multidisciplinary approach to the study of mitochondrial encephalomyopathies. , 1991, Revue neurologique.

[12]  J. Cooper,et al.  The molecular pathology of human respiratory chain defects. , 1991, Revue neurologique.

[13]  P. Matthews,et al.  Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies , 1990, Annals of neurology.

[14]  E. Shoubridge,et al.  Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease , 1990, Cell.

[15]  S. Dimauro,et al.  Widespread tissue distribution of mitochondrial DNA deletions in Kearns‐Sayre syndrome , 1990, Neurology.

[16]  R. Kauppinen,et al.  Brain metabolites as 1H NMR markers of neuronal and glial disorders , 1989, NMR in biomedicine.

[17]  J. Cooper,et al.  Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA , 1989, Annals of neurology.

[18]  E. Shoubridge,et al.  Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. , 1989, Brain : a journal of neurology.

[19]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[20]  A. Schapira,et al.  Mitochondrial myopathies. , 1989, BMJ.

[21]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[22]  E. Costa,et al.  Allosteric modulation of amino acid receptors : therapeutic implications , 1989 .

[23]  C. Epstein,et al.  Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease , 1988, Cell.

[24]  H. Reichmann.  Enzyme activity measured in single muscle fibers in partial cytochrome c oxidase deficiency , 1988, Neurology.

[25]  R. P. Mansfield,et al.  Volume Selection Using Gradients and Selective Pulses , 1987, Annals of the New York Academy of Sciences.

[26]  M. Osame,et al.  Mitochondrial encenhdomyopathy with lachte‐pyruvate elevation and brain infarctions , 1984, Neurology.

[27]  J. Deruaz,et al.  [The pathology of skeletal muscle]. , 1981, Revue medicale de la Suisse romande.

[28]  T. Tsubaki,et al.  Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): Disease entity or a syndrome? Light- and electron-microscopic studies of two cases and review of literature , 1980, Journal of the Neurological Sciences.

[29]  Irwin J. Kopin,et al.  The Biochemical Basis of Neuropharmacology , 1971, The Yale Journal of Biology and Medicine.